Publicacions en què col·labora amb LUIS BRIEVA RUIZ (14)

2024

  1. Can Glatiramer Acetate Prevent Cognitive Impairment by Modulating Oxidative Stress in Patients with Multiple Sclerosis?

    Pharmaceuticals, Vol. 17, Núm. 4

  2. Effects of Vortioxetine on Cognition and Fatigue in Patients with Multiple Sclerosis and Depression: A Case Series Study

    CNS & neurological disorders drug targets, Vol. 23, Núm. 3, pp. 395-401

2023

  1. A prospective study of cellular immune response to booster COVID-19 vaccination in multiple sclerosis patients treated with a broad spectrum of disease-modifying therapies

    Journal of Neurology, Vol. 270, Núm. 5, pp. 2380-2391

  2. Antibodies against the flotillin-1/2 complex in patients with multiple sclerosis

    Brain Communications, Vol. 5, Núm. 2

  3. Mitochondrial Aconitase Enzymatic Activity: A Potential Long-Term Survival Biomarker in the Blood of ALS Patients

    Journal of Clinical Medicine, Vol. 12, Núm. 10

  4. Prophylactic treatment can modify vascular risk biomarkers in high-frequency episodic and chronic migraine patients: a pilot study

    Scientific Reports, Vol. 13, Núm. 1

  5. Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study

    Journal of Clinical Medicine, Vol. 12, Núm. 23

2022

  1. Preventive treatment can reverse cognitive impairment in chronic migraine

    Journal of Headache and Pain, Vol. 23, Núm. 1

  2. Seroprevalence of SARS‐CoV‐2 in a Cohort of Patients with Multiple Sclerosis under Disease‐Modifying Therapies

    Journal of Clinical Medicine, Vol. 11, Núm. 9

  3. The efficacy of combining topiramate and 4-aminopyridine to reduce relapses and interictal progression in two cases of episodic ataxia type 2

    Neurological Sciences, Vol. 43, Núm. 8, pp. 5099-5101

2019

  1. Cardiogenic shock in clinically isolated syndrome

    Neurologia

  2. Impairment of Mitochondrial Redox Status in Peripheral Lymphocytes of Multiple Sclerosis Patients

    Frontiers in Neuroscience, Vol. 13

  3. Lipid profile of cerebrospinal fluid in multiple sclerosis patients: a potential tool for diagnosis

    Scientific reports, Vol. 9, Núm. 1, pp. 11313

2017

  1. Environmental-analytical risk factors influence on the phenotype of amyotrophic lateral sclerosis in a rural setting

    Revista de Neurologia, Vol. 65, Núm. 5, pp. 203-208